Combination of a 5-HT4 agonist with a cholinesterase inhibitor

Details for Australian Patent Application No. 2006328949 (hide)

Owner Novartis AG

Inventors Earnest, David Lewis

Agent Davies Collison Cave

Pub. Number AU-A-2006328949

PCT Pub. Number WO2007/071394

Priority 0526258.9 22.12.05 GB

Filing date 20 December 2006

Wipo publication date 28 June 2007

International Classifications

A61K 31/27 (2006.01)

A61K 31/4045 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

17 July 2008 PCT application entered the National Phase

  PCT publication WO2007/071394 Priority application(s): WO2007/071394

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328950-Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers

2006328948-Sulphonamidoaniline derivatives being Janus kinases inhibitors